Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study

Mostrar otras versiones (1)

IMPORTANCE: There is a need to develop tools to differentiate COVID-19 from bacterial pneumonia at the time of clinical presentation before diagnostic testing is available. OBJECTIVE: To determine if the Ferritin-to-Procalcitonin ratio (F/P) can be used to differentiate COVID-19 from bacterial pneum...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharamti, Amal A., Mei, Fei, Jankousky, Katherine C., Huang, Jin, Hyson, Peter, Chastain, Daniel B., Fan, Jiawei, Osae, Sharmon, Zhang, Wayne W., Montoya, José G., Erlandson, Kristine M., Scherger, Sias J., Franco-Paredes, Carlos, Henao-Martínez, Andrés F., Shapiro, Leland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587841/
https://www.ncbi.nlm.nih.gov/pubmed/33106821
http://dx.doi.org/10.1101/2020.10.20.20216309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587841/
https://www.ncbi.nlm.nih.gov/pubmed/33106821
http://dx.doi.org/10.1101/2020.10.20.20216309

Ejemplares similares